| Ticker | BLUE |
|---|---|
| ISIN | US096ESC0175 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and...
El precio actual de Bluebird bio, Inc. (BLUE) es de 4,97 , con una variación del 0,00%.
Bluebird bio, Inc. opera en el sector Healthcare, industria Biotechnology.